только для медицинских специалистов
Консультант врача. Электронная медицинская библиотека

Консультант врача

Электронная медицинская библиотека

Доступ к библиотеке Версия для слабовидящих
Раздел 16 / 16
Страница 1 / 1

Список литературы:

  1. Ивашкин В.Т., Маев И.В., профессор Трухманов А.С. и др. Клинические рекомендации Российской Гастроэнтерологичеасой Ассоциации по диагностике и лечению пищевода Барретта, 2014.
  2. Лазебник Л., Машарова А., Бордин Д. и др. Многоцентровое исследование “Эпидемиология гастроэзофагеальной рефлюксной болезни в России” (МЭГРЕ): первые итоги // Эксперимент. и клин. гастроэнтерология. – 2009. – № 6. – С. 4-11.
  3. Осипенко М. Ф. и др. Пищевод Барретта–современное состояние проблемы //Российский журнал гастроэнтерол., гепатол., колоп роктол. – 2007. – №. 4. – С. 11.
  4. Пирогов С.С. Эндоскопические методики в уточняющей диагностике и лечении больных с пищеводом барретта : автореф. дис. канд. мед.наук : 14.00.14. - M, 2010.
  5. Armstrong D., Marshall J.K., Chiba N. Canadian Association of Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults – update 2004 // Can. J. Gastroenterol. – 2005. – Vol. 19, N 1. – Р. 15–35.
  6. Avidan B, Sonnenberg A, Schnell TG, et al. Hiatal hernia and acid reflux frequency predict presence and length of Barrett’s esophagus. Dig Dis Sci 2002;47:256–64.
  7. Bennett C., Vakil N., Bergman J., et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process // Gastroenterology. – 2012. – Vol. 143. – P. 336–346
  8. Cameron AJ, Carpenter HA. Barrett’s esophagus, high- grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997;92:586-91.
  9. Cassie L. Booth, Kevin S. Thompson. Barrett’s esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.J Gastrointest Oncol. 2012 September; 3(3): 232–242.
  10. Chandrasoma P, Wickramasinghe K, Ma Y, et al. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis Esophagus 2007;20:36-41.
  11. Chandrasoma P, Wijetunge S, DeMeester S, et al. Columnar-lined esophagus without intestinal metaplasia has no proven risk of adenocarcinoma. Am J Surg Pathol 2012;36:1- 7.
  12. Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 2012;107:850–62.
  13. Edelstein ZR, Bronner MP, Rosen SN, et al. Risk factors for Barrett’s esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study. Am J Gastroenterol 2009;104:834–42.
  14. Endoscopic Classification Review Group. Update on the paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005;37:570–8
  15. Fitzgerald R., di Pietro M., Ragunath K., et al. British Society of gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus // Gut. – 2014. – Vol. 63. - P. 7-63
  16. Hoshihara Y. Endoscopic diagnosis of Barrett esophagus—can Barrett esophagus be diagnosed by endoscopic observation alone?]. Nihon Naika Gakkai Zasshi 2000;89:85–90
  17. Juhasz A, Mittal SK, Lee TH, et al. Prevalence of Barrett esophagus in first-degree relatives of patients with esophageal adenocarcinoma. J Clin Gastroenterol 2011;45:867–71.
  18. Levine DS, Blount PL, Rudolph RE, et al. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol 2000;95:1152–7
  19. McClave SA, Boyce HW Jr, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic diagnostic criterion. Gastrointest Endosc 1987;33:413–16.
  20. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 1988;19:166-78.
  21. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251–5.
  22. Sharma P, Dent J, Armstrong D et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006; 131: 1392-9.
  23. Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus—the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998;93:1033–6.
  24. Sikkema M, De Jonge PJF, Steyerberg EW, et al. Risk of esophageal adenocarcinoma and mortality in patient with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010;8:235–244.
  25. Smith KJ, O’Brien SM, Smithers BM, et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 2005;14(11 Pt 1):2481–6.
  26. Spechler S. J. et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus //Gastroenterology. – 2011. – Т. 140. – №. 3. – С. 1084
  27. Spechler S.J. Screening and surveillance of Barrett’s esophagus // Gastroenterol. Hepatol. – 2005. – Vol. 1,N 2. – P. 91–93.
  28. Theisen J, Nigro JJ, DeMeester TR, et al. Chronology of the Barrett’s metaplasiadysplasia-carcinoma sequence. Dis Esophagus 2004;17:67-70.
  29. Thomas T, Abrams KR, DeCaestecker JS, et al. Meta analysis: cancer risk in Barrett’s oesophagus. Aliment Pharmacol Ther 2007;26:1465–1477.
  30. Vahabzadeh B, Seetharam AB, Cook MB, et al. Validation of the Prague C & M criteria for the endoscopic grading of Barrett’s esophagus by gastroenterology trainees: a multicenter study. Gastrointest Endosc 2012;75:236–41.
  31. Vakil N., van Zanten S., Kahrilas P. et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus // Am. J. Gastroenterol. – 2006. – Vol. 101. – P. 1900-1920).
  32. Van Blankenstein M, Looman CW, Johnston BJ, Caygill CP. Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol. 2005 Mar;100(3):568-76.
  33. Wang K. K., Sampliner R. E. Diagnosis, Surveillance and Therapy of Barrett’s Esophagus //Am J Gastroenterol. – 2008. – Т. 103. – С. 788-797.
  34. Yousef F, Cardwell C, Cantwell MM, et al. The incidence of esophageal cancer and highgrade dysplasia in Barrett’s esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008;168:237–249.
  35. Zhu W, Appelman HD, Greenson JK, et al. A histologically defined subset of high-grade dysplasia in Barrett mucosa is predictive of associated carcinoma. Am J Clin Pathol 2009;132:94-100.

Для продолжения работы требуется вход / регистрация